{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:19:43Z","timestamp":1764260383148,"version":"3.44.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health & Welfare","award":["RS-2021-KH119723"],"award-info":[{"award-number":["RS-2021-KH119723"]}]},{"DOI":"10.13039\/501100002507","name":"Kangwon National University","doi-asserted-by":"publisher","award":["2025 Research Grant"],"award-info":[{"award-number":["2025 Research Grant"]}],"id":[{"id":"10.13039\/501100002507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40266-025-01240-2","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T02:31:27Z","timestamp":1754965887000},"page":"853-862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study"],"prefix":"10.1007","volume":"42","author":[{"given":"Hyunsue","family":"Do","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Nam","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kichul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hyon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Jung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong Kyong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong Min","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Won","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"1","key":"1240_CR1","doi-asserted-by":"publisher","DOI":"10.2196\/45943","volume":"9","author":"Q He","year":"2023","unstructured":"He Q, Mok T-N, Sin T-H, et al. Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction. JMIR Public Health Surveill. 2023;9(1): e45943.","journal-title":"JMIR Public Health Surveill"},{"issue":"8","key":"1240_CR2","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","volume":"6","author":"M Cross","year":"2024","unstructured":"Cross M, Ong KL, Culbreth GT, et al. Global, regional, and national burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024;6(8):e507\u201317.","journal-title":"Lancet Rheumatol"},{"key":"1240_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2165\/00002512-199813030-00006","volume":"13","author":"AG Fam","year":"1998","unstructured":"Fam AG. Gout in the elderly: clinical presentation and treatment. Drugs Aging. 1998;13:229\u201343.","journal-title":"Drugs Aging"},{"issue":"1","key":"1240_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/gucdd2010001","volume":"2","author":"J Lee","year":"2023","unstructured":"Lee J, Sumpter N, Merriman TR, Liu-Bryan R, Terkeltaub R. The evolving landscape of gout in the female: a narrative review. Gout Urate Cryst Depos Dis. 2023;2(1):1\u201316.","journal-title":"Gout Urate Cryst Depos Dis"},{"issue":"47","key":"1240_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005425","volume":"95","author":"B Zhang","year":"2016","unstructured":"Zhang B, Fang W, Zeng X, et al. Clinical characteristics of early-and late-onset gout: a cross-sectional observational study from a Chinese gout clinic. Medicine (Baltimore). 2016;95(47): e5425.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1240_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amjmed.2024.09.018","volume":"138","author":"M-H Tsai","year":"2025","unstructured":"Tsai M-H, Chen Y-Y, Liou H-H, Wang J-T, Fang Y-W. Febuxostat leads to better cardiovascular outcomes compared to allopurinol in patients with advanced chronic kidney disease: A population-based cohort study. Am J Med. 2025;138(2):236-244. e13.","journal-title":"Am J Med"},{"issue":"7","key":"1240_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/clc.23643","volume":"44","author":"L Gao","year":"2021","unstructured":"Gao L, Wang B, Pan Y, Lu Y, Cheng R. Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: a systematic and meta-analysis. Clin Cardiol. 2021;44(7):907\u201316.","journal-title":"Clin Cardiol"},{"key":"1240_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.998441","volume":"13","author":"X Guan","year":"2022","unstructured":"Guan X, Zhang S, Liu J, et al. Cardiovascular safety of febuxostat and allopurinol in patients with gout: a meta-analysis. Front Pharmacol. 2022;13: 998441.","journal-title":"Front Pharmacol"},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/11592750-000000000-00000","volume":"28","author":"LK Stamp","year":"2011","unstructured":"Stamp LK, Jordan S. The challenges of gout management in the elderly. Drugs Aging. 2011;28:591\u2013603.","journal-title":"Drugs Aging"},{"issue":"12","key":"1240_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s40266-017-0512-4","volume":"34","author":"A Abhishek","year":"2017","unstructured":"Abhishek A. Managing gout flares in the elderly: practical considerations. Drugs Aging. 2017;34(12):873\u201380.","journal-title":"Drugs Aging"},{"issue":"3","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/gucdd1030014","volume":"1","author":"M Andr\u00e9s","year":"2023","unstructured":"Andr\u00e9s M. Gout and cardiovascular disease: mechanisms, risk estimations, and the impact of therapies. Gout Urate Cryst Depos Dis. 2023;1(3):152\u201366.","journal-title":"Gout Urate Cryst Depos Dis"},{"issue":"2","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/gucdd1020009","volume":"1","author":"S Gupta","year":"2023","unstructured":"Gupta S, Miller E, Merkin SS, McMahon M, Watson KE, FitzGerald JD. The risk of cardiovascular disease among male and female participants treated for gout in the Multi-Ethnic Study of Atherosclerosis (MESA). Gout Urate Cryst Depos Dis. 2023;1(2):89\u201398.","journal-title":"Gout Urate Cryst Depos Dis"},{"issue":"1","key":"1240_CR13","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1186\/s12889-024-20799-w","volume":"24","author":"Y Li","year":"2024","unstructured":"Li Y, Chen Z, Xu B, et al. Global, regional, and national burden of gout in elderly 1990\u20132021: an analysis for the global burden of disease study 2021. BMC Public Health. 2024;24(1):3298.","journal-title":"BMC Public Health"},{"issue":"2","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/gucdd2020013","volume":"2","author":"P Drivelegka","year":"2024","unstructured":"Drivelegka P, Jacobsson LT, Dehlin M. Gout and gout-related comorbidities: insight and limitations from population-based registers in Sweden. Gout Urate Cryst Depos Dis. 2024;2(2):144\u201356.","journal-title":"Gout Urate Cryst Depos Dis"},{"issue":"1","key":"1240_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/gucdd1010004","volume":"1","author":"T Bardin","year":"2023","unstructured":"Bardin T, Letavernier E, Correas J-M. The gouty kidney: a reappraisal. Gout Urate Cryst Depos Dis. 2023;1(1):25\u201336.","journal-title":"Gout Urate Cryst Depos Dis"},{"key":"1240_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14666","author":"KW Moon","year":"2023","unstructured":"Moon KW, Kim MJ, Shin K. The aftermath of Urate-Lowering TheRApy in gout (ULTRA) registry: the first prospective observational multicenter cohort of Korean patients with gout. Int J Rheum Dis. 2023. https:\/\/doi.org\/10.1111\/1756-185X.14666.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"1240_CR17","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TLTA, Dalbeth N, et al. 2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol. 2015;67(10):2557\u201368.","journal-title":"Arthritis Rheumatol"},{"issue":"35","key":"1240_CR18","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e266","volume":"38","author":"MJ Kim","year":"2023","unstructured":"Kim MJ, Kim JY, Lee JJ, Moon KW, Shin K. Reliability and validity of the Korean version of the Gout Impact Scale. J Korean Med Sci. 2023;38(35): e266.","journal-title":"J Korean Med Sci"},{"key":"1240_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.37897\/RJR.2022.3.3","volume":"3","author":"L Rotaru","year":"2022","unstructured":"Rotaru L, Groppa L, Codreanu CO, et al. Characteristics of clinical manifestations of gout in the elderly people. Rom J Rheumatol. 2022;3:118\u201323.","journal-title":"Rom J Rheumatol"},{"key":"1240_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40520-013-0031-z","volume":"25","author":"F Bolzetta","year":"2013","unstructured":"Bolzetta F, Veronese N, Manzato E, Sergi G. Chronic gout in the elderly. Aging Clin Exp Res. 2013;25:129\u201337.","journal-title":"Aging Clin Exp Res"},{"key":"1240_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-007-0421-7","volume":"28","author":"F De Leonardis","year":"2007","unstructured":"De Leonardis F, Govoni M, Colina M, Bruschi M, Trotta F. Elderly-onset gout: a review. Rheumatol Int. 2007;28:1\u20136.","journal-title":"Rheumatol Int"},{"issue":"7","key":"1240_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3899\/jrheum.110271","volume":"38","author":"JA Singh","year":"2011","unstructured":"Singh JA, Taylor WJ, Simon LS, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011;38(7):1452\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"1240_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1524-4733.2009.00579.x","volume":"12","author":"Y-K Lee","year":"2009","unstructured":"Lee Y-K, Nam H-S, Chuang L-H, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12(8):1187\u201393.","journal-title":"Value Health"},{"issue":"6","key":"1240_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/rheumatology\/kew007","volume":"55","author":"B Wallace","year":"2016","unstructured":"Wallace B, Khanna D, Aquino-Beaton C, et al. Performance of Gout Impact Scale in a longitudinal observational study of patients with gout. Rheumatology. 2016;55(6):982\u201390.","journal-title":"Rheumatology"},{"key":"1240_CR25","doi-asserted-by":"publisher","first-page":"e925593","DOI":"10.12659\/MSM.925593","volume":"26","author":"P Yang","year":"2020","unstructured":"Yang P, Chen Z, Chen YT, et al. Use of the gout impact scale to evaluate quality of life in Chinese subjects with gout: a cross-sectional study. Med Sci Monit. 2020;26:e925593\u2013601.","journal-title":"Med Sci Monit"},{"key":"1240_CR26","doi-asserted-by":"crossref","unstructured":"Hirsch JD, Terkeltaub R, Khanna D, et al. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas. 2010;1:1\u20138.","DOI":"10.2147\/PROM.S8310"},{"issue":"3","key":"1240_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jbspin.2017.05.010","volume":"85","author":"J La-Crette","year":"2018","unstructured":"La-Crette J, Jenkins W, Fernandes G, Valdes AM, Doherty M, Abhishek A. First validation of the gout activity score against gout impact scale in a primary care based gout cohort. Jt Bone Spine. 2018;85(3):323\u20135.","journal-title":"Jt Bone Spine"},{"key":"1240_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10067-012-1956-x","volume":"31","author":"F Bolzetta","year":"2012","unstructured":"Bolzetta F, Veronese N, Manzato E, Sergi G. Tophaceous gout in the elderly: a clinical case review. Clin Rheumatol. 2012;31:1127\u201332.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1240_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105704","volume":"91","author":"T Pascart","year":"2024","unstructured":"Pascart T, Ducoulombier V, Jauffret C. Early-onset gout. Jt Bone Spine. 2024;91(5): 105704.","journal-title":"Jt Bone Spine"},{"issue":"4","key":"1240_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40744-023-00565-x","volume":"10","author":"AJ Amatucci","year":"2023","unstructured":"Amatucci AJ, Padnick-Silver L, LaMoreaux B, Bulbin DH. Comparison between early-onset and common gout: a systematic literature review. Rheumatol Ther. 2023;10(4):809\u201323.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"1240_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/metabo11060399","volume":"11","author":"YS Suh","year":"2021","unstructured":"Suh YS, Noh HS, Kim H-J, et al. Differences in clinical and dietary characteristics, serum adipokine levels, and metabolomic profiles between early-and late-onset gout. Metabolites. 2021;11(6):399.","journal-title":"Metabolites"},{"issue":"8","key":"1240_CR32","first-page":"1582","volume":"31","author":"KL Wallace","year":"2004","unstructured":"Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31(8):1582\u20137.","journal-title":"J Rheumatol"},{"issue":"12","key":"1240_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/acr.23816","volume":"71","author":"M Wu","year":"2019","unstructured":"Wu M, Liu FJ, Chen J, et al. Prevalence and factors associated with bone erosion in patients with gout. Arthritis Care Res. 2019;71(12):1653\u20139.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"1240_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jama.2011.1169","volume":"306","author":"JS Sundy","year":"2011","unstructured":"Sundy JS, Baraf HS, Yood RA, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011;306(7):711\u201320.","journal-title":"JAMA"},{"issue":"10156","key":"1240_CR35","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","volume":"392","author":"M Doherty","year":"2018","unstructured":"Doherty M, Jenkins W, Richardson H, et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet. 2018;392(10156):1403\u201312.","journal-title":"Lancet"},{"issue":"52","key":"1240_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002401","volume":"94","author":"T-C Changchien","year":"2015","unstructured":"Changchien T-C, Yen Y-C, Lin C-L, Lin M-C, Liang J-A, Kao C-H. High risk of depressive disorders in patients with gout: a nationwide population-based cohort study. Medicine. 2015;94(52): e2401.","journal-title":"Medicine"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01240-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:40:42Z","timestamp":1757922042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01240-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01240-2","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"24 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of Kangwon National University Hospital (approval no. KNUH-2025-01-012). This study was conducted in accordance with the Good Clinical Practice guidelines and principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants in the ULTRA registry at the time of enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials (data transparency)"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability (software application or custom code)"}},{"value":"Conceptualization\u2014H. Do and K.W. Moon; data curation\u2014M.J. Kim and K.W. Moon; formal analysis\u2014H. Do; funding acquisition\u2014H. Do and K.W. Moon; writing\u2014original draft\u2014H. Do; writing\u2014review and editing\u2014H. Do, C. Son, H.J. Choi, I.A. Choi, K. Shin, M.J. Kim, S. Kim, Y. Ha, J.K. Ahn, H. Kim, S.W. Lee, C.H. Lee, S.H. Kim, K.M. Son, and K.W. Moon.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}